Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Using CTA to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)

NCT00580008 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT00580008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00580008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Using CTA to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)
Lead sponsor
Corewell Health East
Phase
Observational
Overall status
Completed
Start date
December 31, 2007
Completion date
August 31, 2011
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis of coronary artery bypass graft, coronary artery disease